IP Library Granted Patent US 12,208,230
Granted Patent B2
US 12,208,230 · App. 17/983,894 · Granted Jan 28, 2025

Fluid connector assembly that seals flow paths when the connectors are disconnected

Inventors: Aman Desai (Karnataka, IN); Abin Austin (Kerala, IN); Mohammed Mehtab Khan (Karnataka, IN)
Assignee: CAREFUSION 303, INC.
A61M39/26A61M39/10A61M2039/1027A61M2039/1061A61M2039/263A61M2039/267A61M2205/0216F16L37/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,208,230
App. No.
17/983,894
Granted
Jan 28, 2025
Kind
B2
Abstract

Fluid connector assemblies that seal off fluid paths in the respective connectors are disclosed. When connectors of a fluid connector assembly are connected to each other, respective compressible members in the connectors are displaced, allowing downstream fluid passage through the fluid connector assembly. The connectors maintain a connection by a snap mechanism that provides a threshold retention force. When an external force greater than the threshold force is applied to the fluid connector assembly, the snap mechanism may no longer maintain the connectors together, causing the connectors to decouple from each other. However, each of the compressible members can return to their respective original positions and shapes to seal off respective fluid paths in the connectors, thus preventing further downstream and upstream flow through the fluid connector assembly and limiting or preventing fluid loss.

Claims (50)

1. A fluid connector assembly, comprising:

a first connector, comprising:

a first housing comprising a cavity and a slot,

a post disposed in the first housing, the post comprising an opening, and

a compressible member surrounding the post; and

a second connector configured to couple with the first connector, the second connector comprising:

a second housing comprising a pin, and

a plate coupled with the second housing, wherein the slot permits the first housing to deflect outward when the second housing is inserted into the cavity, and wherein when the second housing is positioned in the cavity, the pin is positioned in the slot and the plate displaces the compressible member and exposes the opening.

2. The fluid connector assembly of claim 1 , wherein when the second housing is removed from the cavity, the compressible member seals the opening.

3. The fluid connector assembly of claim 1 , wherein:

the opening comprises a first opening,

the plate comprises a second opening, and

when the second housing is positioned in the cavity, the post is positioned in the second opening.

4. The fluid connector assembly of claim 3 , wherein the second connector further comprises a second compressible member having a protrusion configured to extend into the second opening.

5. The fluid connector assembly of claim 3 , wherein:

the compressible member comprises a first compressible member,

the second connector further comprises a second compressible member disposed in the second housing, and

when the second housing is positioned in the cavity, the post displaces the second compressible member.

6. The fluid connector assembly of claim 5 , further comprising a channel formed in the post, the channel fluidly connected to the first opening, first opening, the second opening, and the channel define a fluid path.

7. The fluid connector assembly of claim 6 , further comprising a third opening formed in the second compressible member, wherein the third opening further defines the fluid path.

8. The fluid connector assembly of claim 6 , wherein when the plate is disengaged from the first compressible member, the second compressible member seals the second opening.

9. The fluid connector assembly of claim 6 , wherein:

the second housing comprises a fluid inlet,

the first housing comprises a fluid outlet, and

the fluid inlet and the fluid outlet further define the fluid path.

10. The fluid connector assembly of claim 6 , wherein:

the second connector is held in the cavity by a threshold force, and

responsive to an external force, greater than the threshold force, applied to at least one of the first connector and the second connector that removes the second housing from the cavity:

the first compressible member seals the first opening, and

the second compressible member seals the second opening.

11. The fluid connector assembly of claim 6 , wherein the second compressible member is movable relative to the plate.

12. A method for regulating a fluid for an intravenous application, the method comprising, by a fluid connector assembly:

providing a first connector, the first connector comprising:

a first housing comprising a slot and a post, the post defining a channel,

a first compressible member surrounding the post,

an opening formed in the post, the opening fluidly connected to the channel, and a cavity; and

receiving, at the cavity, a second connector such that the housing deflects outward, the second connector comprising:

a second housing comprising a pin and a plate, and

a second compressible member; and

receiving the pin within the slot;

displacing, by the plate, the first compressible member to uncover the opening; and

displacing, by the post, the second compressible member, thereby allowing the fluid to pass through the opening.

13. The method of claim 12 , further comprising positioning the post, based on receiving the second connector, at least partially in the second connector.

14. The method of claim 12 , further comprising removing, by an external force, the second connector from the cavity, thereby causing the first compressible member to seal the opening.

15. The method of claim 12 , wherein displacing the first compressible member comprising compressing the first compressible member.

16. The method of claim 15 , wherein compressing the first compressible member comprising moving the first compressible member relative to the post.

17. The method of claim 12 , wherein displacing the second compressible member comprising compressing the second compressible member.

18. The method of claim 17 , wherein compressing the second compressible member comprising moving the second compressible member relative to the plate.

19. The method of claim 12 , wherein displacing the second compressible member comprising disengaging the second compressible member from the plate.

20. The method of claim 12 , further comprising removing, based on displacing the second compressible member, a protrusion of the second compressible member from an opening of the plate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2023
From: DESAI, AMAN; AUSTIN, ABIN; KHAN, MOHAMMED MEHTAB
To: CAREFUSION 303, INC.
Reel/Frame 062639/0829 →
Continuity (1)
Related Publication 20240151338A1 · May 9, 2024
References Cited (169)
US 5492147A · Challender · 1996 [cited by examiner]
US 5713856A · Eggers et al. · 1998 [cited by applicant]
US 5820614A · Erskine · 1998 [cited by examiner]
US 6874522B2 · Anderson et al. · 2005 [cited by applicant]
US 7004934B2 · Vaillancourt · 2006 [cited by examiner]
US 7040598B2 · Raybuck · 2006 [cited by applicant]
US 7044441B2 · Doyle · 2006 [cited by examiner]
US 7153296B2 · Mitchell · 2006 [cited by applicant]
US 7350764B2 · Raybuck · 2008 [cited by applicant]
US 7396051B2 · Baldwin · 2008 [cited by examiner]
US 7631660B2 · deCler · 2009 [cited by examiner]
US 7658205B1 · Edelman · 2010 [cited by examiner]
US 7763013B2 · Baldwin et al. · 2010 [cited by applicant]
US 7766394B2 · Sage et al. · 2010 [cited by applicant]
US 7794675B2 · Lynn · 2010 [cited by applicant]
US 7803139B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7803140B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7815614B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7918243B2 · Diodati et al. · 2011 [cited by applicant]
US 7998134B2 · Fangrow et al. · 2011 [cited by applicant]
US 8123738B2 · Vaillancourt · 2012 [cited by applicant]
US 8142418B2 · McMichael et al. · 2012 [cited by applicant]
US 8211069B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8262628B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8361408B2 · Lynn · 2013 [cited by applicant]
US 8480968B2 · Lynn · 2013 [cited by applicant]
US 8777908B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8777909B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8795256B1 · Smith · 2014 [cited by applicant]
US 8888758B2 · Mansour · 2014 [cited by applicant]
US 8899267B2 · Diodati et al. · 2014 [cited by applicant]
US 8910919B2 · Bonnal et al. · 2014 [cited by applicant]
US 8974425B2 · Tachizaki · 2015 [cited by examiner]
US 8974437B2 · Williams et al. · 2015 [cited by applicant]
US 9039047B2 · Imai · 2015 [cited by examiner]
US 9114242B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126028B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126029B2 · Fangrow et al. · 2015 [cited by applicant]
US 9168366B2 · Fangrow · 2015 [cited by examiner]
US 9192753B2 · Lopez et al. · 2015 [cited by applicant]
US 9234616B2 · Carrez et al. · 2016 [cited by applicant]
US 9358379B2 · Fangrow, Jr. · 2016 [cited by applicant]
US 9409007B2 · Yeh · 2016 [cited by examiner]
US 9433769B2 · Bayly · 2016 [cited by applicant]
US 9468749B2 · Mansour et al. · 2016 [cited by applicant]
US 9492649B2 · Carrez · 2016 [cited by examiner]
US 9636492B2 · Fangrow, Jr. · 2017 [cited by applicant]
US 9724504B2 · Fangrow, Jr. et al. · 2017 [cited by applicant]
US 9724505B2 · Williams et al. · 2017 [cited by applicant]
US 9861805B2 · Dennis et al. · 2018 [cited by applicant]
US 9933094B2 · Fangrow · 2018 [cited by examiner]
US 9974939B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 9974940B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 10029086B2 · Nowak et al. · 2018 [cited by applicant]
US 10156306B2 · Fangrow · 2018 [cited by applicant]
US 10173045B2 · Mansour · 2019 [cited by applicant]
US 10179203B1 · Huslage et al. · 2019 [cited by applicant]
US 10286203B2 · Gagliardoni · 2019 [cited by examiner]
US 10315025B2 · Phillips et al. · 2019 [cited by applicant]
US 10322274B2 · Ueda · 2019 [cited by examiner]
US 10398887B2 · Fangrow, Jr. et al. · 2019 [cited by applicant]
US 10441507B2 · Sanders · 2019 [cited by applicant]
US 10518078B2 · Stjernberg Bejhed et al. · 2019 [cited by applicant]
US 10569073B2 · Hallisey et al. · 2020 [cited by applicant]
US 10625068B2 · Leuthardt et al. · 2020 [cited by applicant]
US 10655768B2 · Jones et al. · 2020 [cited by applicant]
US 10697570B2 · Fangrow · 2020 [cited by applicant]
US 10744315B2 · Sanders · 2020 [cited by examiner]
US 10842982B2 · Fangrow, Jr. · 2020 [cited by applicant]
US 10857346B2 · Dennis et al. · 2020 [cited by applicant]
US 10864362B2 · Jones et al. · 2020 [cited by applicant]
US 10881847B2 · Lynn · 2021 [cited by applicant]
US 11123534B2 · Chen · 2021 [cited by examiner]
US 11168818B2 · Fangrow · 2021 [cited by applicant]
US 11207514B2 · Kakinoki · 2021 [cited by examiner]
US 11235135B2 · Tsai · 2022 [cited by examiner]
US 11273297B2 · Kakinoki · 2022 [cited by applicant]
US 11298518B2 · Fuchs · 2022 [cited by examiner]
US 11484471B2 · Sanders · 2022 [cited by applicant]
US 11491084B2 · Ueda · 2022 [cited by examiner]
US 20040215158A1 · Anderson · 2004 [cited by applicant]
US 20050090805A1 · Shaw et al. · 2005 [cited by applicant]
US 20060129109A1 · Shaw et al. · 2006 [cited by applicant]
US 20070088292A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070088293A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070088294A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070225635A1 · Lynn · 2007 [cited by applicant]
US 20080039803A1 · Lynn · 2008 [cited by applicant]
US 20090001720A1 · Cheon · 2009 [cited by examiner]
US 20110106046A1 · Hiranuma · 2011 [cited by applicant]
US 20140249487A1 · Lynn · 2014 [cited by applicant]
US 20140330254A1 · Rosenberger et al. · 2014 [cited by applicant]
US 20160000363A1 · Jones et al. · 2016 [cited by applicant]
US 20180200147A1 · Sanders · 2018 [cited by applicant]
US 20190184152A1 · Kakinoki · 2019 [cited by applicant]
US 20190282797A1 · Tsai · 2019 [cited by applicant]
US 20200113784A1 · Lopez et al. · 2020 [cited by applicant]
US 20200179672A1 · Kakinoki · 2020 [cited by applicant]
US 20200215319A1 · Fangrow, Jr. et al. · 2020 [cited by applicant]
US 20200284385A1 · Fangrow · 2020 [cited by applicant]
US 20200323734A1 · Ueda et al. · 2020 [cited by applicant]
US 20200338331A1 · Sanders · 2020 [cited by applicant]
US 20210069484A1 · Tsai · 2021 [cited by applicant]
US 20210077803A1 · Lynn · 2021 [cited by applicant]
US 20210252267A1 · Fangrow, Jr. · 2021 [cited by applicant]
US 20210388926A1 · Martin et al. · 2021 [cited by applicant]
US 20210393938A1 · Lynn et al. · 2021 [cited by applicant]
US 20220260189A1 · Deuse · 2022 [cited by applicant]
US 20220282814A1 · Fangrow · 2022 [cited by applicant]
US 20230355946A1 · Kuriyama · 2023 [cited by examiner]
EP 1678070A2 · 2006 [cited by applicant]
EP 1517723B1 · 2007 [cited by applicant]
EP 1622675B1 · 2009 [cited by applicant]
EP 2144634A1 · 2010 [cited by applicant]
EP 2298407A1 · 2011 [cited by applicant]
EP 2694132A1 · 2014 [cited by applicant]
EP 2562456B1 · 2014 [cited by applicant]
EP 2782633A1 · 2014 [cited by applicant]
EP 1842002B1 · 2015 [cited by applicant]
EP 2736582B1 · 2015 [cited by applicant]
EP 2089094B1 · 2016 [cited by applicant]
EP 2219721B1 · 2017 [cited by applicant]
EP 2753396B1 · 2017 [cited by applicant]
EP 2736584B1 · 2018 [cited by applicant]
EP 3305361A1 · 2018 [cited by applicant]
EP 2271398B1 · 2018 [cited by applicant]
EP 2480281B1 · 2018 [cited by applicant]
EP 2790750B1 · 2018 [cited by applicant]
EP 2331191B1 · 2019 [cited by applicant]
EP 3079756B1 · 2019 [cited by applicant]
EP 2121114B1 · 2019 [cited by applicant]
EP 2719419B1 · 2019 [cited by applicant]
EP 2956204B1 · 2019 [cited by applicant]
EP 3421077B1 · 2019 [cited by applicant]
EP 3530313A1 · 2019 [cited by applicant]
EP 3538201A1 · 2019 [cited by applicant]
EP 3570807A1 · 2019 [cited by applicant]
EP 3570809A1 · 2019 [cited by applicant]
EP 2536463B1 · 2020 [cited by applicant]
EP 3381505B1 · 2020 [cited by applicant]
EP 3538201B1 · 2020 [cited by applicant]
EP 1904152B1 · 2020 [cited by applicant]
EP 2150307B1 · 2020 [cited by applicant]
EP 3313490B1 · 2021 [cited by applicant]
EP 3760275A1 · 2021 [cited by applicant]
EP 3851155A1 · 2021 [cited by applicant]
EP 3517164B1 · 2021 [cited by applicant]
EP 3954355A1 · 2022 [cited by applicant]
EP 3960229A1 · 2022 [cited by examiner]
EP 3973044A1 · 2022 [cited by applicant]
EP 3305361B1 · 2022 [cited by applicant]
EP 3134052B1 · 2022 [cited by applicant]
EP 3530313B1 · 2022 [cited by applicant]
WO WO2021099437A1 · 2021 [cited by applicant]
WO WO2021180675A1 · 2021 [cited by applicant]
WO WO2021252197A1 · 2021 [cited by applicant]
WO WO2022042956A1 · 2022 [cited by applicant]
WO WO2022149339A1 · 2022 [cited by applicant]
WO WO2022207560A1 · 2022 [cited by applicant]
Bangert, Bill, “Shorter times to blood transfusion associated with decreased death risk in trauma patients”, Medical Xpress, Apr. 14, 2016, https://medicalxpress.com/news/2016-04-shorter-blood-transfusion-decreased-deat… [cited by applicant]
Icumedical, “ChemoClave™ Needlefree Close System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemoclave. [cited by applicant]
Icumedical, “ChemoLock™ Needlefree Closed System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemolock. [cited by applicant]
Ivteam, “Force-activated separation IV connectors”, 2022, Retrieved from the internet https://www.ivteam.com/intravenous-literature/force-activated-separation-iv-connectors/ [Last retrieved Jan. 13, 2023]. [cited by applicant]
Lineus Medical, SafeBreak Product Features and Benefits Brochure, May 2021, mkg 0058 5/21 Rev. 02. [cited by applicant]
Przen, “Lineus Medical Goes International, Signs ONEY for Distribution in Korea”, PRZen Online Press Release Distribution, PrZen/33448014, MKG-0130 Rev 00, Retrieved from the internet https://przen.com/pr/lineus-medical… [cited by applicant]
Rickard, et al., “Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial”, BMJ Open, Sep. 23, 2015;5(9):e008689, doi: 10.1136/b… [cited by applicant]
Tada Group AB, LinkedIn Post “ReLink granted patent in Japan”, LinkedIn, Mar. 2022, retrieved from the internet https://se.linkedin.com/company/tadamedical?trk=public_post_reshare_feed-actor-image&original_referer= [Las… [cited by applicant]
Tribology, “Coefficient of friction, Rolling resistance and Aerodynamics”, date unknown, https://www.tribology-abc.com/abc/cof.htm. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2023/032211, dated Dec. 21, 2023, 9 pages. [cited by applicant]